Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they have expanded their usage of mint Lesion™ over the years, how it has changed their clinical studies, and his view on the potential of structured data for research.
Potential of using structured data from clinical trials and routine for AI and radiomics research
Related Resources
Related Resources
Raising our awareness in pediatric cancer
The terms rare, uncommon, infrequent are commonly used to describe the occurrence of cancer in children – from a prevalence perspective, “only”…
The Mint Mission
Join our three Sales Directors, Felix Gruler, Aditya Jayaram, and Steffen Rupp, in their discussion about Mint Medical’s mission statements and how we…
Enhancing flexibility and communication while saving costs and time in clinical trials
Emily Ferris and Alex Arbuckle describe how using mint Lesion™ has enhanced their clinical trial operations, enabling “a more cooperative approach…